Clinical trials show progress in migraine frequency, skin cancer prevention

-
4:24
Evers and GOP leaders meet on taxes, arrest of Milwaukee County...
-
2:29
Hundreds protest demanding obstruction charges be dropped for...
-
2:00
As abandoned boat remains on Milwaukee’s lakefront, people...
-
1:46
Schlesinger’s Saturday Showcase (4/26)...Community clean up,...
-
2:08
Quiet weekend before the forecast turns stormy to start the week
-
2:51
How far did super fans travel to attend the 2025 NFL Draft in...
-
2:27
Football fans don’t let rain, wind dampen their spirits during...
-
1:13
Protesters gather in Milwaukee, call for charges against Judge...
-
2:22
Bucks come home for Game 3, fans encouraged to wear green for...
-
2:59
Milwaukee County Circuit Judge Hannah Dugan arrested on charges...
-
2:04
Meet CBS 58’s Pet of the Week: Halo
-
5:33
CBS 58’s Feel Good Fridays: Art Walk, robotics and outdoor...
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.